|
MPS Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
3.36 Cr.
|
P/BV
|
3.12
|
Book Value (Rs.)
|
0.57
|
|
52 Week High/Low (Rs.)
|
4/2
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
28/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.47 | -0.43 | -0.55 | -0.07 | -2.31 |
| Diluted EPS (Rs.) | -0.47 | -0.43 | -0.55 | -0.07 | -2.31 |
| Cash EPS (Rs.) | -0.39 | -0.35 | -0.47 | 0.19 | -2.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.56 | 1.03 | 1.46 | 2.00 | 2.07 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.56 | 1.03 | 1.46 | 2.00 | 2.07 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| PBDIT / Share (Rs.) | -0.37 | -0.36 | -0.48 | -0.21 | -2.06 |
| PBIT / Share (Rs.) | -0.45 | -0.44 | -0.56 | -0.48 | -2.35 |
| PBT / Share (Rs.) | -0.45 | -0.44 | -0.56 | -0.48 | -2.35 |
| Net Profit / Share (Rs.) | -0.46 | -0.43 | -0.54 | -0.07 | -2.31 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | -1290.32 | 0.00 |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | -2876.76 | 0.00 |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | -2880.22 | 0.00 |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | -437.31 | 0.00 |
| Return on Networth / Equity (%) | -83.08 | -42.21 | -37.63 | -3.70 | -111.78 |
| Return on Capital Employeed (%) | -68.24 | -38.85 | -35.47 | -22.83 | -96.84 |
| Return On Assets (%) | -9.62 | -8.36 | -10.31 | -1.39 | -39.07 |
| Total Debt / Equity (X) | 6.90 | 3.69 | 2.42 | 1.52 | 0.48 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.25 | 0.27 | 0.29 | 0.33 | 0.32 |
| Quick Ratio (X) | 0.19 | 0.20 | 0.22 | 0.24 | 0.24 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.08 | 0.03 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -1438.08 | -563.32 | -1722.46 | -373.22 | -7579.04 |
| Interest Coverage Ratio (Post Tax) (%) | -1800.93 | -662.72 | -1955.76 | -125.49 | -8500.46 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 13.53 | 13.40 | 10.77 | 8.45 | 3.35 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 261.01 | 0.00 |
| EV / EBITDA (X) | -18.88 | -19.00 | -11.65 | -20.23 | -0.85 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 82.05 | 0.00 |
| Price / BV (X) | 5.63 | 3.12 | 1.44 | 0.69 | 0.36 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 86.88 | 0.00 |
| EarningsYield | -0.14 | -0.13 | -0.26 | -0.05 | -3.08 |
